Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views :

The Appetite Economy: What GLP-1s Really Mean for Your Dining Room

|
|

Imagine a Tuesday regular—the kind every operator builds a business on. They still book the same corner table, still arrive with the same two friends, still stay for two hours. But their order has changed. The appetizer is now the entrée. The glass of Pinot is replaced with sparkling water with lime. The dessert menu is set aside, unexamined. The server clears a plate that’s one-third full—though the regular insists the food was delicious.

Using this scenario as an illustration, the resulting cheque could be about 40 per cent lower than a traditional dining occasion. The regular is still there, but the economics of their visit have quietly been rewritten. And this is a pattern that’s repeating.


GLP-1 receptor agonists—Ozempic, Wegovy, Mounjaro, Zepbound and a growing family of successors—have moved from medical curiosity to mass-market reality with startling speed. In the United States, somewhere between one in eight and nearly one in five adults now takes a GLP-1 medication, depending on the survey (the National Restaurant Association’s consumer research puts it at roughly one in eight), and the trajectory points up: nearly three in ten American adults not currently on the medication tell the association they would consider it if cost and access improved. If those intentions become behaviour, as many as four in ten could eventually be on a GLP-1.

Canada is not watching from the sidelines. Estimates of domestic adoption vary by survey—Ipsos pegged usage at up to 1.4 million Canadians in late 2025, while a Leger Healthcare survey in early 2026 put it closer to three million adults—but every measure agrees on the essentials: the number is large, it is growing, and cost is the main restraint. Millions more Canadians say they want the medications than currently take them, and that barrier is expected to erode as generic semaglutide arrives on the heels of the January 2026 patent expiry. Notably for our industry, Leger found roughly 30 per cent of Canadian users report visiting restaurants or ordering takeout less often since starting the medication.

Beyond that top-line figure, however, granular Canadian behavioural data has been scarce—a gap Foodservice Facts 2026, Restaurants Canada’s flagship industry research report and forecast, begins to close this October. But appetite physiology doesn’t stop at the border, so the U.S. findings can offer Canadian operators an early preview and the outlines of a playbook slowly coming into focus.

Separating panic from pattern

The first thing the U.S. data makes clear is that the doomsday scenario—dining rooms emptied by pharmaceutical appetite suppression—has not materialized, and likely won’t.

Receipt-tracking research from Circana, released in January 2026, found that GLP-1 users have largely maintained their restaurant visit frequency, trimming the average number of items per trip by only about one per cent. Several major chains report seeing no obvious GLP-1 signal in their sales data at all. And analyst projections are similarly measured: research from William Blair concluded that even a doubling of GLP-1 usage over the next five years would shave less than one per cent off industry sales growth and roughly five per cent off traffic. This is meaningful, but potentially manageable for an industry accustomed to rapid menu adaptation.

That said, “manageable in aggregate” can conceal real pressure in specific places. Dinner traffic has fallen about six per cent among consistent GLP-1 users, according to restaurant marketing firm RRD, whose analysis was reported by CNBC—and adoption is still climbing: J.P. Morgan estimates the American user base could triple to more than 30 million people by 2030. In Canada, Ipsos projects the domestic user base could triple by decade’s end as well. The wave is not receding.

The story is not only about whether guests show up; it’s equally about what happens after they sit down. Research from the Ohio Restaurant & Hospitality Alliance and Ohio State University, published this summer, found that 46 per cent of GLP-1 users skip alcohol, desserts and sugar-sweetened beverages entirely when dining out. Those are, for most full-service operators, the three highest-margin categories on the menu. The genuine P&L exposure from GLP-1s is not the empty seat. It’s the full seat with the hollowed-out cheque.

There is also a generational wrinkle that complicates the gloom. In U.S. research from Acosta Group, about a third of consumers overall report dining out less—but nearly half of Gen Z and Millennial respondents say they’re dining out more since starting the medication, ordering differently as they go, with more than 40 per cent sharing an entrée more often. Whether Canadian users will prove quite so enthusiastic is an open question; early Canadian survey data points to a quieter version of the same story, with the majority of users reporting no change in how often they visit restaurants. Either way, the directional read is consistent on both sides of the border: the visit survives the medication. For younger guests especially, the medication appears to reframe the restaurant visit as social first and food-and-drink occasion second.

Which points to the reframe this whole conversation needs. As the Ohio alliance’s Andy Piccolantonio put it, GLP-1s are changing how people eat, “but not why they love restaurants.” The threat is not lost guests. It’s misaligned menus.

Meet the GLP-1 guest

To adapt, it helps to understand what’s actually happening at the table. GLP-1 medications slow gastric emptying and act on the brain’s appetite signalling, which means those taking the medication feel full sooner and for a longer period of time. Users routinely describe being satisfied after just a few bites of a rich dish. So, the 12-ounce striploin—once the high point of a night out—becomes an awkward proposition: $40 of steak against four bites of appetite.

Many also report that alcohol simply loses its appeal, a phenomenon researchers are studying for its own therapeutic potential, but which lands hard on the beverage line of a restaurant P&L.

Survey after survey converges on the same portrait of the GLP-1 diner’s preferences. National Restaurant Association research finds the most common ordering changes are choosing smaller portions, prioritizing protein-rich dishes and adding more vegetables. Leger’s Canadian data echoes this on the retail side, with about a third of users buying more fresh produce and protein-rich foods. An EY-Parthenon survey found that among users consuming fewer calories, about 70 per cent say they are snacking less, which helps explain why sides, breads and impulse add-ons are fading from tickets even as entrée orders hold.

Crucially though, guests are not asking restaurants to become diet-conscious food clinics. Rather, they are implicitly asking for permission to eat less without friction, waste or embarrassment. And they will reward the operators who grant it: a William Blair survey of 300 GLP-1 users found that nearly half (48 per cent) would dine out more often if smaller-format options were available. This preference was especially pronounced among consumers under 45.

Here is the opportunity hiding in that finding. Despite rising demand, the Ohio research found only nine per cent of restaurants currently offer anything resembling a GLP-1-friendly menu. The gap between what a fast-growing guest segment wants and what the industry currently offers is, in trend terms, a white space, and it will not stay open for long.

The operator’s playbook

Intelligent accommodation comes down to four strategy clusters, in rough order of urgency.

  1. Right-size, don’t discount.

The instinct to simply shrink portions and prices proportionally is a margin trap. The smarter move is to build small formats with intentional economics: half portions and “petite” plates priced at a healthy per-ounce premium, tasting formats, and pick-two or mix-and-match bundles that feel complete without feeling excessive. Researchers behind the Ohio study concluded that flexibility in portioning, shareable dishes and clearly identified options is precisely how restaurants can protect both traffic and revenue. In New York, concepts have begun experimenting openly—one Manhattan beer hall made headlines with a deliberately miniature burger-fries-and-beer combo — but the principle scales quietly to any menu: give the light eater a purpose-built option rather than forcing an awkward compromise, a boxed-up half-meal, or a plate of visible waste.

Shareability deserves special attention. The entrée built for two, the family-style middle of the table, the progression of small plates or similar formats let a mixed party of medicated and non-medicated diners eat together without anyone ordering defensively. They also happen to align with how younger guests already prefer to dine.

2. Rebuild the cheque without alcohol and full dessert.

This is the tougher challenge, and the one most industry commentary skips. If nearly half of a growing guest segment is walking past your three richest margin categories, the answer is to give them somewhere else to spend.

The most direct substitution is a serious zero-proof program: not a token mocktail, but a beverage list with the craft, storytelling and price integrity of a cocktail menu. Sommelier-grade non-alcoholic pairings, premium teas, sparkling options and an inspired coffee service can recapture a meaningful share of abandoned beverage spend, from GLP-1 users and the broader moderation-minded public alike.

On the food side, consider add-ons that match the new appetite: protein-forward starters, a raw bar selection, or composed vegetable dishes that justify their price. For dessert, the premium two-bite format is the smart move—an espresso-and-single-truffle pairing or a miniature tart or pastry captures the emotional aspects of the ritual and recaptures some of the dessert revenue from a guest who would likely refuse a full slice.

It’s also worth reengineering the take-home play. Consider a “now and later” format: the guest orders a full-priced dish; half arrives plated tonight, and the other half lands with the cheque, packaged for tomorrow’s lunch. The kitchen portions and packages the meal on the line rather than boxing table scraps, so the second half travels well by design. The guest captures full value from a full-priced order without the soggy sadness of a doggy bag, and the operator protects the cheque, cuts plate waste and intentionally solves a future meal occasion for the guest.

The appetite didn’t vanish; it redistributed across the day. Smart operators will follow it there.

3. Get the language right.

Menu communication is where good intentions can go sideways. An explicitly labelled “GLP-1 menu” is a genuine trade-off: welcoming to some guests, clinical and stigmatizing to others, and potentially alienating to the majority who aren’t on the medication at all. Most operators will do better with inclusive framing—“lighter,” “right-sized,” “petite plates”—supported by the labelling GLP-1 users actually rely on: protein counts, fibre callouts, and clear portion cues.

The National Restaurant Association’s research points to the same direction, finding that better menu labelling and greater visibility for wellness-focused items are among the clearest ways to connect with this segment. The elegant part is that none of this reads as medical accommodation. Protein-forward, vegetable-rich, transparently portioned menus are simply where broader consumer preference is heading. Ipsos’s 2026 Canadian trend research frames GLP-1s as an accelerant of an “intentional consumer” who was emerging anyway. So, when you build for the GLP-1 guest, you’re actually building for the market.

Servers should be able to steer a guest toward lighter formats naturally, without commentary, questions or a raised eyebrow at the barely touched plate. Hospitality, in this context, means making eating less feel unremarkable.

4. Sell the occasion, not the volume.

This is the strategic reframe. If the guest consumes less, the experience must carry more of the value. Research consistently shows that GLP-1 users still deeply value the social dimension of dining out—the Ohio study’s headline finding was that, while users may make different choices at the table, they haven’t stopped wanting to be there. That means pacing, ambiance, service warmth and shareable formats aren’t soft considerations; they are the product. The operators who thrive in the smaller-appetite economy will be the ones who long ago stopped selling calories by the pound and started selling a reason to gather.

Not every segment feels this equally

Industry analysis suggests quick service, fast casual and any concept whose value proposition rests on sheer portion size will feel the shift first—abundance-as-value is the positioning most directly undermined by suppressed appetites. Full-service restaurants with flexible menus have more room to manoeuvre, and protein-centric concepts are arguably positioned to benefit outright; steakhouse and churrasco operators have been quick to note that their menus already look like a GLP-1 user’s grocery list.

For Canadian operators, the practical takeaway is to audit your own concept’s dependence on volume, alcohol and dessert —the three pressure points—rather than waiting for national data to confirm what your ticket averages will tell you first.

The value equation, rewritten

For decades, the restaurant industry’s default definition of value was quantity: the overflowing plate, the bottomless refill, the portion that guaranteed leftovers. GLP-1s are forcing a different equation: guests who want to feel satisfied, not stuffed. But the industry has already been drifting in this direction. Health-consciousness, moderation in drinking, protein obsession, waste aversion: the medication is an accelerant, not the origin, of the intentional eater. That’s reassuring.

The accommodations operators make for GLP-1 users will also serve the broader dining public of 2026 and beyond. As usage increases on both sides of the border, the question is no longer whether these guests will be in your dining room. They already are, sitting at the corner table on Tuesday, glass of sparkling water in hand, waiting to see which restaurants figure out how to keep their cheque, their routine—and their loyalty—whole.

For more information on GLP-1s and other nutritional trends, look for Foodservice Facts 2026, available September 24.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.